Carterra advances lab-in-the-loop drug discovery through new scientific collaboration
Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery.
Read original article on The Medical News →Related news
-
Bio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy development
United Kingdom
-
ELRIG and The Protein Society announce keynote speakers for Protein Sciences in Drug Discovery 2026
United Kingdom
-
From 'what's wrong?' to 'what's strong': Exploring the personal strengths of people living with diabetes
United Kingdom
-
Longer sleep may be linked to a higher risk of kidney disease in people with type 2 diabetes
United Kingdom
-
Neighbors Flock to Rescue a Wounded Owl Tangled Up in Barbed Wire
United Kingdom
-
FDA-cleared urine test delivers results for invasive aspergillosis within hours
United Kingdom
-
A study spanning 118 countries reveals a divide in pain and aging
United Kingdom
-
Global injury crisis highlights urgent need for smarter trauma care
United Kingdom